Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Liability Protections For Pandemic Vaccine Makers Provided In Spending Law

Executive Summary

The 2006 defense appropriations law includes liability protections for manufacturers of pandemic countermeasures but not more extensive patent incentives that had been proposed in some bills focused on bioterror products

You may also be interested in...



FDA Makes Preemption Case Once And For All In Final Labeling Rule

The product liability preemption language in FDA's physician labeling rule applies to all drugs regardless of whether they are regulated by the final rule

FDA Makes Preemption Case Once And For All In Final Labeling Rule

The product liability preemption language in FDA's physician labeling rule applies to all drugs regardless of whether they are regulated by the final rule

Avian Flu Plan From Administration Places Vaccines First, Antivirals Second

The Bush Administration's pandemic flu preparedness plans call for a dramatic expansion in the stockpiling of antivirals, an increase expected to be largely paid for by the states

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel